Using Big Data To Improve Medication Use And Safety
Funder
National Health and Medical Research Council
Funding Amount
$851,980.00
Summary
More than 1 in 3 Australians report having 3 or more chronic conditions and the majority of older people now take 5 or more medicines. The safety of medicines on their own, and in combination is therefore an issue of significant importance to Australia. This research will develop and assess data methods to monitor the safety of medicines after they are released on the market and then provide and assess interventions for GPs to support improvements in medicine use.
Improving The Prevention, Treatment And Management Of Cardiovascular & Chronic Disease In The Community
Funder
National Health and Medical Research Council
Funding Amount
$774,540.00
Summary
The identification, prevention and management of cardiovascular and chronic disease risk factors and understanding impact on clinical outcomes is fundamental to improving health and well-being. The program of work encapsulated in this application utilises modern epidemiological research methods involving large scale clinical trials, registries and epidemiological modelling to advance our understanding and provide new directions for cardiovascular disease prevention and management.
Ovarian and endometrial cancer affect >3,200 women each year in Australia and 3 or 4 women die from these cancers every day. The overall aim of my program of research is to reduce the burden of these cancers in future generations of Australian women by increasing our understanding of (i) what causes them, (ii) how we can optimise patient management to enhance patient outcomes and (ii) how lifestyle changes might improve quality and life and survival, for women who are diagnosed with them.
Striking The Balance: Combining Best Patient Outcomes And Cost-effective Interventions To Manage Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$782,370.00
Summary
This research will combine effective patient outcomes with strategic spending of health dollars. Through detailed analyses of current and recent clinical trials on cardiovascular disease, this project will identify treatments that provide the most benefit to patients’ quality of life and, crucially, will also be the most cost-effective to fund. This will pave the way for similar processes to be used in other areas of health to develop cost-effective healthcare programs for vulnerable groups.
The identification, prevention and management of chronic disease risk factors and understanding impact on clinical outcomes is fundamental to improving health and well-being. The program of work encapsulated in this application utilises a number of research methods to advance our understanding and provide new directions for cardiovascular disease prevention and management.